Progressing Home Health Rehabilitation for Older Adults

March 5, 2024 updated by: University of Colorado, Denver

Progressing Home Health Rehabilitation Paradigms for Older Adults

This research study explores the effects of a progressive, multi-component intervention following a stay in the hospital or rehabilitation facility. The purpose of this research study is to compare a multi-component intervention (higher intensity exercise, nutritional supplementation, and greater emphasis on functionally enhanced care transitions) with usual care physical therapy.

Study Overview

Detailed Description

Declines in physical function as a result of acute illness are strongly and independently associated with a number of adverse health events for older adults. Home Health (HH) physical therapy may be the ideal venue for addressing these declines in physical function because around 3 million older adults receive HH services following discharge from acute or post-acute facilities. However, as currently structured, HH care does not appear to adequately restore function, as evidenced by poor long-term outcomes and high rates of hospital readmission. Diminished physical function has been particularly implicated as a risk factor for re-hospitalization --older adults with lower levels of ambulatory activity are 6 times more likely to be re-hospitalized than those with greater ambulatory activity. A more intensive approach to HH physical therapy for older adults has great potential to maximize physical function and reduce hospital readmissions. Therefore, the investigators have developed a high intensity home-based, progressive, interdisciplinary, multi-component (PMC) intervention that directly addresses the functional deficits seen after hospitalization. This intervention will include intensive rehabilitation, a care transitions program, and daily protein supplementation. The investigators will conduct a two-arm, randomized clinical trial (RCT) of 200 participants admitted to HH from an acute or post-acute facility. Participants will receive either 1) an intensive, PMC intervention using resistance exercise and evidenced-based motor control training to improve physical function, along with nutritional supplementation and emphasis on functionally enhanced care transitions or 2) usual care (UC) physical therapy. The primary goal of this investigation is to determine if PMC intervention, initiated upon admission to HH, improves physical function, as measured by performance and self-report assessments, more than UC physical therapy. The investigators will also examine the effects on fatigue, balance confidence, and activities of daily living. In an exploratory analysis, the effects of the PMC intervention on re-hospitalization rates, nursing home placement, emergency room visits, and falls after discharge from the acute care hospital will also be examined. All outcomes will be examined at baseline, 30, 60 (primary endpoint), 90 and 180 days. If successful in improving patient function and decreasing re-hospitalization rates, PMC intervention holds potential for future health care cost savings.

Study Type

Interventional

Enrollment (Actual)

353

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver, Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 65 years of age and older
  2. Referred to home care physical therapy following acute medical deconditioning
  3. Have at least 3 comorbid conditions including those listed below:

    • Chronic Obstructive Pulmonary Disease
    • Gastrointestinal Bleed
    • Urinary Tract Infection
    • Pneumonia
    • Chronic ulcerative wounds
    • Diabetes
    • Hypertension
    • Depression/mental health
    • Irritable Bowel Syndrome
    • Hernia
    • Post-op pancreatic surgery
    • Osteoporosis/OA/RA/Gout
    • Heart Disease
    • Hypercholesterolemia
    • Peripheral Arterial Disease
    • Spinal Stenosis
    • Dehydration
    • Syncope
    • Atrial fibrillation
    • Hypo/Hyperthyroid
    • Renal Failure (no dialysis)
    • Post-op bowel surgery
    • Congestive Heart Failure
  4. Be ambulatory without human assistance prior to hospitalization
  5. Be English-speaking

Exclusion Criteria: (one or more):

  1. Acute lower extremity fracture with weight-bearing restriction
  2. "Elective" joint replacement surgery
  3. Lower extremity amputation
  4. Acute cardiac surgery
  5. Terminal illness
  6. Active cancer treatment in which exercise is contraindicated
  7. Deep vein thrombosis/pulmonary embolus (DVT/PE)
  8. Recent stroke (within 1 yr)
  9. Score of <20 on SLUMS (as of 08.16.2018, revised to exclusion #14)
  10. Inability to ambulate 10 feet without human assistance at time of hospital discharge
  11. Gait Speed <0.3m/s or >1.0 m/s
  12. Progressive neurodegenerative diagnosis (e.g. Parkinson's, MS, ALS)
  13. Use of illegal substances
  14. Clinical discretion of study physician to exclude patients who are determined to be unsafe and/or inappropriate to participate in high intensity rehabilitation as defined by the inclusion/exclusion criteria
  15. Active involvement of Adult Protection Services
  16. Current dialysis treatment
  17. Prisoners or those on probation or other alternative sentencing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Progressive Multi-Component (PMC)
High intensity strength training protocol, daily protein supplementation, functionally enhanced transitions of care
Participants in the "Progressive Multi-component" intervention group will receive 1) high intensity physical therapy, 2) protein supplement, and 3) emphasis on functionally enhanced transitions of care following discharge from post-acute setting. High intensity physical therapy will include progressive resistance training, multi-planar motor control and gait exercises, and high intensity activities of daily living training. Functionally enhanced transitions of care protocol includes a personal health record with 5 domains that are addressed in an interdisciplinary manner with the patient. Participants will receive 12 intervention visits over 60 days. Participants will also receive a home exercise program.
Active Comparator: Enhanced Usual Care (EUC)

Low intensity rehabilitation protocol, standard education for nutrition, standard transitions of care

Name of Participant Arm updated to "Enhanced Usual Care" from "Usual Care" effective 8/16/18 to distinguish from Passive Comparator "True Usual Care" group.

Participants in the "Enhanced Usual Care" group will receive standardized physical therapy following discharge from acute hospitalization. The activities of therapy will include basic strength training, single-planar motor control and gait exercises, and activities of daily living training. Participants will receive 12 intervention visits over 60 days. Participants will also receive a standardized home exercise program and standard nutritional education.

Name of Participant Arm updated to "Enhanced Usual Care" from "Usual Care" effective 8/16/18 to distinguish from Passive Comparator "True Usual Care" group.

No Intervention: True Usual Care (TUC)

Real-world home health rehabilitation, real-world education for nutrition, real-world transitions of care, non-randomized observation

Participants in the "True Usual Care" group will receive physical therapy following discharge from acute hospitalization. Activities and number of visits are not protocolized and are provided by real world home health care providers per physician orders.

Participant Arm added effective 8/16/18.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery (SPPB)
Time Frame: Change in SPPB from baseline to 60 days post randomization
SPPB is a well-accepted global measure of lower extremity function which consists of walking speed, chair stands, and balance. It is a well-studied composite measure and a strong predictor of disability, institutionalization, and morbidity in older adults. SPPB will also be assessed at 30, 90, 180 days post-randomization.
Change in SPPB from baseline to 60 days post randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Physical Performance Test (mPPT)
Time Frame: Change in mPPT from baseline to 60 days post randomization
mPPT assesses 7 tasks. Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item. The maximal score is 28 and includes tasks that involve upper and lower extremity function. Test-retest reliability for the modified PPT score is 0.96. The instrument is sensitive to change and has been used in exercise trials with frail elders. mPPT will also be assessed at 30, 90, 180 days post-randomization.
Change in mPPT from baseline to 60 days post randomization
Fast walking speed (4MW)
Time Frame: Change in 4MW from baseline to 60 days post randomization
Will be assessed at the fastest, safe speed for each participant over 4 meters. Fastest walking assesses capacity for performance of certain activities (e.g. crossing a street before the light changes). Fast walking speed will also be assessed at 30, 90, 180 days post-randomization.
Change in 4MW from baseline to 60 days post randomization
ActivPAL
Time Frame: Change in physical activity from baseline to 60 days post randomization
Accelerometer-based physical activity examines volume and intensity of physical activity in which participants engage. Participants will wear a thigh-mounted activPAL physical activity monitoring device for up to 10 days to determine mean steps and activity counts per day (PAL Technologies, Glasgow, Scotland). Physical activity will also be defined as daily time spent in sitting, standing, and stepping. The activPAL has been found to be reliable (ICC≥0.99), valid (% Error =0.94% compared to video analysis; gold standard), and suitably sensitive to detect difference/change is similar populations. Physical activity will also be assessed at 30, 90, 180 days post-randomization.
Change in physical activity from baseline to 60 days post randomization
Falls Efficacy Scale-International
Time Frame: Change in Falls Efficacy Scale-International from baseline to 60 days post randomization
Questionnaire assesses concern about falling during performance of activities of daily living. Participants rate 16 individual activities on a scale from 1 (not at all concerned) to 4 (very concerned). Falls Efficacy Scale-International will also be assessed at 30, 90, 180 days post-randomization.
Change in Falls Efficacy Scale-International from baseline to 60 days post randomization
Fatigue Severity Scale (FSS)
Time Frame: Change in FSS from baseline to 60 days post randomization
A nine item questionnaire that quantifies the degree of fatigue and the impact of fatigue on activities of daily living in clinical populations. Participants score each of 9 components on a scale of 1 to 7. The aggregate score ranges from 9 (no impact) to 64 (profound impact of fatigue on activities of daily living). A total score of less than 36 suggests that a participant is not suffering from fatigue. The FSS is reliable (r=0.56-0.89), valid (α=0.97), and sensitive to change. FSS will also be assessed at 30, 90, 180 days post-randomization.
Change in FSS from baseline to 60 days post randomization
Patient Activation Measure (PAM)
Time Frame: Change in PAM from baseline to 60 days post randomization
Identifies patient motivation levels regarding their healthcare. Reliably predicts future ER visits, hospital admissions, and medication/ therapy adherence. The survey classifies patient activation levels on a scale from 1 (low activation/motivation) to 4 (high activation/motivation). Patients who score higher on the PAM survey tend to be hospitalized less and adhere to medication and therapy schedules more.
Change in PAM from baseline to 60 days post randomization
Grip Strength
Time Frame: Change in Grip Strength from baseline to 60 days post randomization
Grip strength is a simple and reliable surrogate of overall muscle strength and a valid predictor of physical disability and mobility limitation. Grip strength will also be assessed at 30, 90, 180 days post-randomization.
Change in Grip Strength from baseline to 60 days post randomization

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls, Emergency Department visits, nursing home days, hospitalizations
Time Frame: Quantification of falls, ED visits, nursing home days, and hospitalizations at 30, 60, 90, and 180 days post randomization
Patients will be given a log to record any falls, ED visits, hospitalizations or nursing home stays. Falls will be defined as an unintentional change in position resulting in coming to rest on the ground or other lower level.
Quantification of falls, ED visits, nursing home days, and hospitalizations at 30, 60, 90, and 180 days post randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer E Stevens-Lapsley, MPT, PhD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2016

Primary Completion (Actual)

May 6, 2022

Study Completion (Actual)

June 3, 2022

Study Registration Dates

First Submitted

September 14, 2016

First Submitted That Met QC Criteria

September 14, 2016

First Posted (Estimated)

September 19, 2016

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 15-2125
  • R01NR016209 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Deconditioning

Clinical Trials on Progressive Multi-Component (PMC)

3
Subscribe